HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Coty Jovan Ginseng NRG men's scent targets younger consumers, will bow in May.

This article was originally published in The Rose Sheet

Executive Summary

COTY JOVAN GINSENG NRG-IZING MEN's FRAGRANCE OFFERINGS with a "fresh" musk that builds on the Jovan brand heritage while courting a younger customer, according to the Joh A. Benckiser division. Bowing in May, the "energizing" scent is the company's first introduction under the Jovan umbrella since Benckiser bought the brand and its parent company, Quintessence, in 1992. The scent is the sixth in the Jovan stable, which includes the original Jovan Musk for women, which bowed in 1972, Jovan Musk for Men (1973), Jovan Sex Appeal for men (1975), Jovan White Musk for women (1990) and Jovan White Musk for Men (1992). The four-SKU Jovan Ginseng NRG fragrance line-up includes two cologne sprays, a cologne pour and a conditioning aftershave.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS004937

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel